市場調査レポート

商品コード

肉腫治療薬の世界市場 2024-2028

Global sarcoma therapeutics market 2024-2028

出版日: 2024年06月13日
発行: TechNavio
ページ情報: 英文 143 Pages
納期: 即納可能

カスタマイズ可能

価格

PDF (Single User License)

USD 2,500 376,725円

レポートPDFをご購入者の1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 4,000 602,760円

レポートPDFを同一組織内のすべての方にて共有ご使用頂けるライセンスです。ご利用人数に制限はありません。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は制限なく何回でも可能ではありますが、印刷物のご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=150.69円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

肉腫治療薬市場は2023-2028年に11億1,080万米ドル、予測期間中のCAGRは8.51％で成長すると予測されています。

当レポートでは、肉腫治療薬市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。患者支援プログラム、戦略的提携の増加、新薬の発売などが市場を牽引しています。

市場範囲
基準年	2024
終了年	2028
予測期間	2024-2028
成長モメンタム	加速
前年比2024年	7.67%
CAGR	8.51%
増分額	11億1,080万米ドル

本調査では、今後数年間の肉腫治療薬市場成長を牽引する主要因の1つとして、疾病治療のための新薬の研究開発を挙げています。また、財政支援プログラムや償還スキーム、再生医療の出現は市場の大きな需要につながります。

地域別セグメンテーション
地域別比較
北米：市場規模と予測 2023-2028
欧州：市場規模と予測 2023-2028
アジア：市場規模と予測 2023-2028
世界のその他の地域：市場規模と予測 2023-2028
米国：市場規模と予測 2023-2028
中国：市場規模と予測 2023-2028
ドイツ：市場規模と予測 2023-2028
カナダ：市場規模と予測 2023-2028
英国：市場規模と予測 2023-2028
市場機会：地域別

第9章促進要因・課題・機会・抑制要因

市場促進要因
市場の課題
促進要因と課題の影響
市場の機会・抑制要因

第10章競合情勢

概要
競合情勢
混乱の状況
業界のリスク

第11章競合分析

企業プロファイル
企業の市場ポジショニング
Agios Inc.
Athenex Inc.
Bayer AG
Eisai Co. Ltd.
GlaxoSmithKline Plc
Ipsen Pharma
Johnson and Johnson Services Inc.
Karyopharm Therapeutics Inc.
Novartis AG
PharmaMar SA

第12章付録

図表

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Company Market Positioning
Exhibits9: Parent Market
Exhibits10: Data Table on - Parent Market
Exhibits11: Market characteristics analysis
Exhibits12: Value Chain Analysis
Exhibits13: Offerings of companies included in the market definition
Exhibits14: Market segments
Exhibits15: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits16: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits17: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Historic Market Size - Data Table on Global Sarcoma Therapeutics Market 2018 - 2022 ($ million)
Exhibits20: Historic Market Size - Type Segment 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Type - Market share 2023-2028 (%)
Exhibits31: Data Table on Type - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Soft tissue sarcoma - Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on Soft tissue sarcoma - Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on Soft tissue sarcoma - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Soft tissue sarcoma - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Osteosarcoma - Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on Osteosarcoma - Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on Osteosarcoma - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Osteosarcoma - Year-over-year growth 2023-2028 (%)
Exhibits42: Market opportunity by Type ($ million)
Exhibits43: Data Table on Market opportunity by Type ($ million)
Exhibits44: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits45: Chart on Market share by geography 2023-2028 (%)
Exhibits46: Data Table on Market share by geography 2023-2028 (%)
Exhibits47: Chart on Geographic comparison
Exhibits48: Data Table on Geographic comparison
Exhibits49: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits50: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits51: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits52: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits53: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits54: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits55: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits56: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits57: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits58: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits59: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits60: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits61: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits62: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits63: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits64: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits65: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits66: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits67: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits68: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits69: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits70: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits71: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits72: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits73: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits74: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits75: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits76: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits77: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits78: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits79: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits80: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits81: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits82: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits83: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits85: Market opportunity by geography ($ million)
Exhibits86: Data Tables on Market opportunity by geography ($ million)
Exhibits87: Impact of drivers and challenges in 2023 and 2028
Exhibits88: Overview on criticality of inputs and factors of differentiation
Exhibits89: Overview on factors of disruption
Exhibits90: Impact of key risks on business
Exhibits91: Companies covered
Exhibits92: Matrix on companies position and classification
Exhibits93: Agios Inc. - Overview
Exhibits94: Agios Inc. - Product / Service
Exhibits95: Agios Inc. - Key offerings
Exhibits96: Athenex Inc. - Overview
Exhibits97: Athenex Inc. - Product / Service
Exhibits98: Athenex Inc. - Key offerings
Exhibits99: Bayer AG - Overview
Exhibits100: Bayer AG - Business segments
Exhibits101: Bayer AG - Key news
Exhibits102: Bayer AG - Key offerings
Exhibits103: Bayer AG - Segment focus
Exhibits104: Eisai Co. Ltd. - Overview
Exhibits105: Eisai Co. Ltd. - Business segments
Exhibits106: Eisai Co. Ltd. - Key offerings
Exhibits107: Eisai Co. Ltd. - Segment focus
Exhibits108: GlaxoSmithKline Plc - Overview
Exhibits109: GlaxoSmithKline Plc - Business segments
Exhibits110: GlaxoSmithKline Plc - Key news
Exhibits111: GlaxoSmithKline Plc - Key offerings
Exhibits112: GlaxoSmithKline Plc - Segment focus
Exhibits113: Ipsen Pharma - Overview
Exhibits114: Ipsen Pharma - Business segments
Exhibits115: Ipsen Pharma - Key offerings
Exhibits116: Ipsen Pharma - Segment focus
Exhibits117: Johnson and Johnson Services Inc. - Overview
Exhibits118: Johnson and Johnson Services Inc. - Business segments
Exhibits119: Johnson and Johnson Services Inc. - Key news
Exhibits120: Johnson and Johnson Services Inc. - Key offerings
Exhibits121: Johnson and Johnson Services Inc. - Segment focus
Exhibits122: Karyopharm Therapeutics Inc. - Overview
Exhibits123: Karyopharm Therapeutics Inc. - Product / Service
Exhibits124: Karyopharm Therapeutics Inc. - Key offerings
Exhibits125: Novartis AG - Overview
Exhibits126: Novartis AG - Business segments
Exhibits127: Novartis AG - Key news
Exhibits128: Novartis AG - Key offerings
Exhibits129: Novartis AG - Segment focus
Exhibits130: PharmaMar SA - Overview
Exhibits131: PharmaMar SA - Business segments
Exhibits132: PharmaMar SA - Key offerings
Exhibits133: PharmaMar SA - Segment focus
Exhibits134: Inclusions checklist
Exhibits135: Exclusions checklist
Exhibits136: Currency conversion rates for US$
Exhibits137: Research methodology
Exhibits138: Information sources
Exhibits139: Data validation
Exhibits140: Validation techniques employed for market sizing
Exhibits141: Data synthesis
Exhibits142: 360 degree market analysis
Exhibits143: List of abbreviations

Product Code: IRTNTR72566

The sarcoma therapeutics market is forecasted to grow by USD 1110.8 mn during 2023-2028, accelerating at a CAGR of 8.51% during the forecast period. The report on the sarcoma therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by patient assistance programs, increasing strategic alliances, and launch of novel drugs.

Technavio's sarcoma therapeutics market is segmented as below:

Market Scope
Base Year	2024
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	7.67%
CAGR	8.51%
Incremental Value	$1110.8mn

By Type

Soft tissue sarcoma
Osteosarcoma

By Geography

North America
Europe
Asia
Rest of World (ROW)

This study identifies the r and d of new drugs for oh treatment as one of the prime reasons driving the sarcoma therapeutics market growth during the next few years. Also, financial assistance programs and reimbursements schemes and advent of regenerative medicine will lead to sizable demand in the market.

The report on the sarcoma therapeutics market covers the following areas:

Sarcoma therapeutics market sizing
Sarcoma therapeutics market forecast
Sarcoma therapeutics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading sarcoma therapeutics market vendors that include Adaptimmune Therapeutics plc, Advenchen Laboratories LLC, Agenus Inc., Agios Inc., Athenex Inc., Bayer AG, Bristol Myers Squibb Co., Eisai Co. Ltd., Eli Lilly and Co., GlaxoSmithKline Plc, Ipsen Pharma, Johnson and Johnson Services Inc., Karyopharm Therapeutics Inc., LadRx Corp., Mirati Therapeutics Inc., Novartis AG, Pfizer Inc., PharmaMar SA, and SillaJen Co. Ltd.. Also, the sarcoma therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
2.2 Market characteristics
- Market characteristics analysis
2.3 Value chain analysis
- Value Chain Analysis

3 Market Sizing

3.1 Market definition
- Offerings of companies included in the market definition
3.2 Market segment analysis
- Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global Sarcoma Therapeutics Market 2018 - 2022
- Historic Market Size - Data Table on Global Sarcoma Therapeutics Market 2018 - 2022 ($ million)
4.2 Type segment analysis 2018 - 2022
- Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.3 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.4 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Type

6.1 Market segments
- Chart on Type - Market share 2023-2028 (%)
- Data Table on Type - Market share 2023-2028 (%)
6.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type
6.3 Soft tissue sarcoma - Market size and forecast 2023-2028
- Chart on Soft tissue sarcoma - Market size and forecast 2023-2028 ($ million)
- Data Table on Soft tissue sarcoma - Market size and forecast 2023-2028 ($ million)
- Chart on Soft tissue sarcoma - Year-over-year growth 2023-2028 (%)
- Data Table on Soft tissue sarcoma - Year-over-year growth 2023-2028 (%)
6.4 Osteosarcoma - Market size and forecast 2023-2028
- Chart on Osteosarcoma - Market size and forecast 2023-2028 ($ million)
- Data Table on Osteosarcoma - Market size and forecast 2023-2028 ($ million)
- Chart on Osteosarcoma - Year-over-year growth 2023-2028 (%)
- Data Table on Osteosarcoma - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Type
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)

7 Customer Landscape

7.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

8 Geographic Landscape

8.1 Geographic segmentation
- Chart on Market share by geography 2023-2028 (%)
- Data Table on Market share by geography 2023-2028 (%)
8.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
8.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
8.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
8.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
8.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
8.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
8.8 China - Market size and forecast 2023-2028
- Chart on China - Market size and forecast 2023-2028 ($ million)
- Data Table on China - Market size and forecast 2023-2028 ($ million)
- Chart on China - Year-over-year growth 2023-2028 (%)
- Data Table on China - Year-over-year growth 2023-2028 (%)
8.9 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)
8.10 Canada - Market size and forecast 2023-2028
- Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Chart on Canada - Year-over-year growth 2023-2028 (%)
- Data Table on Canada - Year-over-year growth 2023-2028 (%)
8.11 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ million)
- Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)
8.12 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)

9 Drivers, Challenges, and Opportunity/Restraints

9.1 Market drivers
9.2 Market challenges
9.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
9.4 Market opportunities/restraints

10 Competitive Landscape

10.1 Overview
10.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
10.3 Landscape disruption
- Overview on factors of disruption
10.4 Industry risks
- Impact of key risks on business

11 Competitive Analysis

11.1 Companies profiled
- Companies covered
11.2 Market positioning of companies
- Matrix on companies position and classification
11.3 Agios Inc.
- Agios Inc. - Overview
- Agios Inc. - Product / Service
- Agios Inc. - Key offerings
11.4 Athenex Inc.
- Athenex Inc. - Overview
- Athenex Inc. - Product / Service
- Athenex Inc. - Key offerings
11.5 Bayer AG
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key news
- Bayer AG - Key offerings
- Bayer AG - Segment focus
11.6 Eisai Co. Ltd.
- Eisai Co. Ltd. - Overview
- Eisai Co. Ltd. - Business segments
- Eisai Co. Ltd. - Key offerings
- Eisai Co. Ltd. - Segment focus
11.7 GlaxoSmithKline Plc
- GlaxoSmithKline Plc - Overview
- GlaxoSmithKline Plc - Business segments
- GlaxoSmithKline Plc - Key news
- GlaxoSmithKline Plc - Key offerings
- GlaxoSmithKline Plc - Segment focus
11.8 Ipsen Pharma
- Ipsen Pharma - Overview
- Ipsen Pharma - Business segments
- Ipsen Pharma - Key offerings
- Ipsen Pharma - Segment focus
11.9 Johnson and Johnson Services Inc.
- Johnson and Johnson Services Inc. - Overview
- Johnson and Johnson Services Inc. - Business segments
- Johnson and Johnson Services Inc. - Key news
- Johnson and Johnson Services Inc. - Key offerings
- Johnson and Johnson Services Inc. - Segment focus
11.10 Karyopharm Therapeutics Inc.
- Karyopharm Therapeutics Inc. - Overview
- Karyopharm Therapeutics Inc. - Product / Service
- Karyopharm Therapeutics Inc. - Key offerings
11.11 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
11.12 PharmaMar SA
- PharmaMar SA - Overview
- PharmaMar SA - Business segments
- PharmaMar SA - Key offerings
- PharmaMar SA - Segment focus

12 Appendix

12.1 Scope of the report
12.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
12.3 Currency conversion rates for US$
- Currency conversion rates for US$
12.4 Research methodology
- Research methodology
12.5 Data procurement
- Information sources
12.6 Data validation
- Data validation
12.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
12.8 Data synthesis
- Data synthesis
12.9 360 degree market analysis
- 360 degree market analysis
12.10 List of abbreviations
- List of abbreviations

肉腫治療薬の世界市場 2024-2028

Global sarcoma therapeutics market 2024-2028

目次

第1章エグゼクティブサマリー

第2章市場情勢

第3章市場規模の評価

第4章市場規模実績

第5章ファイブフォース分析

第6章市場セグメンテーション：タイプ別

第7章顧客情勢

第8章地域別情勢

第9章促進要因・課題・機会・抑制要因

第10章競合情勢

第11章競合分析

第12章付録

Table of Contents

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Historic Market Size

5 Five Forces Analysis

6 Market Segmentation by Type

7 Customer Landscape

8 Geographic Landscape

9 Drivers, Challenges, and Opportunity/Restraints

10 Competitive Landscape

11 Competitive Analysis

12 Appendix

肉腫治療薬の世界市場 2024-2028

Global sarcoma therapeutics market 2024-2028

目次

第1章 エグゼクティブサマリー

第2章 市場情勢

第3章 市場規模の評価

第4章 市場規模実績

第5章 ファイブフォース分析

第6章 市場セグメンテーション：タイプ別

第7章 顧客情勢

第8章 地域別情勢

第9章 促進要因・課題・機会・抑制要因

第10章 競合情勢

第11章 競合分析

第12章 付録

Table of Contents

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Historic Market Size

5 Five Forces Analysis

6 Market Segmentation by Type

7 Customer Landscape

8 Geographic Landscape

9 Drivers, Challenges, and Opportunity/Restraints

10 Competitive Landscape

11 Competitive Analysis

12 Appendix

第1章エグゼクティブサマリー

第2章市場情勢

第3章市場規模の評価

第4章市場規模実績

第5章ファイブフォース分析

第6章市場セグメンテーション：タイプ別

第7章顧客情勢

第8章地域別情勢

第9章促進要因・課題・機会・抑制要因

第10章競合情勢

第11章競合分析

第12章付録